Total Payments
$24,307
2024 Payments
$288.59
Companies
24
Transactions
81
Medicare Patients
6,032
Medicare Billing
$1.6M
Payment Breakdown by Category
Education$12,061 (49.6%)
Other$10,000 (41.1%)
Travel$1,187 (4.9%)
Food & Beverage$1,059 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $12,061 | 9 | 49.6% |
| Grant | $10,000 | 1 | 41.1% |
| Travel and Lodging | $1,187 | 4 | 4.9% |
| Food and Beverage | $1,059 | 67 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $13,256 | 10 | $0 (2024) |
| Medtronic Vascular, Inc. | $10,013 | 2 | $0 (2020) |
| GlaxoSmithKline, LLC. | $251.79 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $110.05 | 6 | $0 (2022) |
| Genentech USA, Inc. | $104.99 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $91.84 | 5 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $52.12 | 2 | $0 (2024) |
| Grifols USA, LLC | $45.34 | 2 | $0 (2024) |
| GENZYME CORPORATION | $42.35 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $36.60 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.59 | 14 | GlaxoSmithKline, LLC. ($76.84) |
| 2023 | $13,324 | 15 | Intuitive Surgical, Inc. ($13,204) |
| 2022 | $131.46 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27.43) |
| 2021 | $113.59 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($29.21) |
| 2020 | $10,053 | 5 | Medtronic Vascular, Inc. ($10,013) |
| 2019 | $48.07 | 3 | AstraZeneca Pharmaceuticals LP ($24.20) |
| 2018 | $236.46 | 24 | GlaxoSmithKline, LLC. ($105.19) |
| 2017 | $111.81 | 5 | Genentech USA, Inc. ($66.99) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Pulmonology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $52.17 | General |
| Category: SURGERY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Pulmonology | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 11/09/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 11/02/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiology | ||||||
| 10/20/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 10/13/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $242.00 | General |
| Category: SURGERY | ||||||
| 10/12/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $231.86 | General |
| Category: SURGERY | ||||||
| 10/11/2023 | Intuitive Surgical, Inc. | ION (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 10/11/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: SURGERY | ||||||
| 10/06/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $694.04 | General |
| Category: SURGERY | ||||||
| 10/06/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,658 | 13,563 | $1.7M | $472,912 |
| 2022 | 26 | 1,439 | 14,697 | $1.5M | $471,738 |
| 2021 | 29 | 1,500 | 11,789 | $1.1M | $380,773 |
| 2020 | 28 | 1,435 | 7,038 | $732,441 | $232,254 |
Total Patients
6,032
Total Services
47,087
Medicare Billing
$1.6M
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2182 | Injection, mepolizumab, 1 mg | Office | 2023 | 32 | 6,100 | $610,000 | $142,369 | 23.3% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 37 | 4,545 | $454,500 | $138,462 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 595 | $146,370 | $56,009 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 185 | 326 | $107,906 | $43,551 | 40.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 314 | $35,168 | $14,618 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $32,648 | $9,649 | 29.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 41 | 249 | $27,390 | $9,303 | 34.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 37 | 207 | $31,050 | $7,908 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $26,208 | $7,901 | 30.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 143 | 150 | $23,700 | $6,665 | 28.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 55 | $27,720 | $6,567 | 23.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 143 | 149 | $23,542 | $6,312 | 26.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 132 | 137 | $20,824 | $4,081 | 19.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 29 | 110 | $11,550 | $3,385 | 29.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 85 | 262 | $16,443 | $2,895 | 17.6% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 17 | 17 | $46,512 | $2,781 | 6.0% |
| 92526 | Treatment of swallowing and feeding disorder | Office | 2023 | 33 | 37 | $6,327 | $2,468 | 39.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 30 | $7,770 | $2,260 | 29.1% |
| 92523 | Evaluation of speech sound production with evaluation of language comprehension and expression | Office | 2023 | 12 | 12 | $4,800 | $2,151 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,816 | $879.48 | 31.2% |
| 92610 | Evaluation of swallowing function | Office | 2023 | 11 | 11 | $2,167 | $734.25 | 33.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 26 | 28 | $2,156 | $683.80 | 31.7% |
| 97129 | Therapy procedure for a range of mental processes, initial 15 minutes | Office | 2023 | 32 | 36 | $2,340 | $637.92 | 27.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 15 | 15 | $1,350 | $284.67 | 21.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 16 | 16 | $800.00 | $223.80 | 28.0% |
About Dr. Muhammad Athar, MD
Dr. Muhammad Athar, MD is a Pulmonary Disease healthcare provider based in North Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1063673606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Athar, MD has received a total of $24,307 in payments from pharmaceutical and medical device companies, with $288.59 received in 2024. These payments were reported across 81 transactions from 24 companies. The most common payment nature is "Education" ($12,061).
As a Medicare-enrolled provider, Athar has provided services to 6,032 Medicare beneficiaries, totaling 47,087 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location North Chesterfield, VA
- Active Since 06/17/2008
- Last Updated 05/19/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1063673606
Products in Payments
- Da Vinci Surgical System (Device) $10,256
- ION (Device) $3,000
- TRELEGY ELLIPTA (Drug) $123.68
- NUCALA (Biological) $89.10
- OFEV (Drug) $80.84
- DUPIXENT (Biological) $61.08
- ACTHAR (Biological) $52.12
- TEZSPIRE (Biological) $49.10
- Prolastin-C Liquid (Biological) $45.34
- Esbriet (Biological) $38.00
- XOLAIR (Drug) $36.60
- Zemaira (Drug) $33.42
- (8874) inCourage (Device) $30.50
- ANORO (Drug) $30.05
- STIOLTO RESPIMAT (Drug) $29.21
- TYVASO (Drug) $28.53
- ZERBAXA (Drug) $27.66
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $27.09
- Adempas (Drug) $24.98
- FASENRA (Drug) $24.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.